As a type of aggressive cancer, triple-negative breast cancer (TNBC) includes the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 protein (HER-2). Here, ESR1 is linked to triple-negative breast carcinoma.